13/09/2024
Press Release: 54th GST council meeting
GST Council recommends Group of Ministers (GoM) on life and health insurance-related GST with the existing GoM on Rate Rationalisation; to submit a report by the end of October 2024.
GST Council also recommends the formation of a GoM to study the future of compensation cess.
GST Council recommends exempting the supply of research and development services by a Government Entity, or a research association, university, college, or other institution notified under section 35 of the Income Tax Act using government or private grants.
GST Council recommends a reduction in GST rates on cancer drugs – Trastuzumab Deruxtecan, Osimertinib, and Durvalumab from 12% to 5%.
GST Council recommends rolling out a pilot for B2C e-Invoicing.